535 related articles for article (PubMed ID: 17524746)
21. Kidney biopsy in HIV: beyond HIV-associated nephropathy.
Fine DM; Perazella MA; Lucas GM; Atta MG
Am J Kidney Dis; 2008 Mar; 51(3):504-14. PubMed ID: 18295067
[No Abstract] [Full Text] [Related]
22. Nephrotic syndrome due to thrombotic microangiopathy (TMA) as the first manifestation of human immunodeficiency virus infection: recovery before antiretroviral therapy without specific treatment against TMA.
Sacristán Lista F; Saavedra Alonso AJ; Oliver Morales J; Vázquez Martul E
Clin Nephrol; 2001 May; 55(5):404-7. PubMed ID: 11393387
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and natural history of HIV-associated nephropathy.
Atta MG
Adv Chronic Kidney Dis; 2010 Jan; 17(1):52-8. PubMed ID: 20005489
[TBL] [Abstract][Full Text] [Related]
24. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy.
Marras D; Bruggeman LA; Gao F; Tanji N; Mansukhani MM; Cara A; Ross MD; Gusella GL; Benson G; D'Agati VD; Hahn BH; Klotman ME; Klotman PE
Nat Med; 2002 May; 8(5):522-6. PubMed ID: 11984599
[TBL] [Abstract][Full Text] [Related]
25. The pathogenesis of HIV-associated nephropathy.
Kaufman L; Collins SE; Klotman PE
Adv Chronic Kidney Dis; 2010 Jan; 17(1):36-43. PubMed ID: 20005487
[TBL] [Abstract][Full Text] [Related]
26. Dramatic improvement of renal dysfunction in a human immunodeficiency virus-infected woman treated with highly active antiretroviral therapy.
Chemlal K; Nochy D; Kenouch S; Joly V; Carbon C
Clin Infect Dis; 2000 Sep; 31(3):805-6. PubMed ID: 11017834
[TBL] [Abstract][Full Text] [Related]
27. Emergencies in HIV--part 2.
Rewari BB; Purohit V; Chhabra RM; Bhagwan J
J Assoc Physicians India; 2008 Oct; 56():783-6. PubMed ID: 19263705
[TBL] [Abstract][Full Text] [Related]
28. The nephrologist in the HAART era.
Izzedine H; Deray G
AIDS; 2007 Feb; 21(4):409-21. PubMed ID: 17301559
[No Abstract] [Full Text] [Related]
29. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
[TBL] [Abstract][Full Text] [Related]
30. The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN Study).
Vellozzi C; Brooks JT; Bush TJ; Conley LJ; Henry K; Carpenter CC; Overton ET; Hammer J; Wood K; Holmberg SD;
Am J Epidemiol; 2009 Mar; 169(5):642-52. PubMed ID: 19074775
[TBL] [Abstract][Full Text] [Related]
31. Antiretroviral therapy in the treatment of HIV-associated nephropathy.
Atta MG; Gallant JE; Rahman MH; Nagajothi N; Racusen LC; Scheel PJ; Fine DM
Nephrol Dial Transplant; 2006 Oct; 21(10):2809-13. PubMed ID: 16864598
[TBL] [Abstract][Full Text] [Related]
32. Impact of HAART therapy on co-infection of tuberculosis and HIV cases for 9 years in Taiwan.
Tseng SH; Jiang DD; Hoi HS; Yang SL; Hwang KP
Am J Trop Med Hyg; 2009 Apr; 80(4):675-7. PubMed ID: 19346398
[TBL] [Abstract][Full Text] [Related]
33. Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and management.
Szczech LA
Clin Infect Dis; 2001 Jul; 33(1):115-9. PubMed ID: 11389504
[TBL] [Abstract][Full Text] [Related]
34. Risks of cardiovascular disease in patients receiving antiretroviral therapy for HIV infection: implications for treatment.
Steinhart CR; Emons MF
AIDS Read; 2004 Feb; 14(2):86-90, 93-5. PubMed ID: 14997864
[TBL] [Abstract][Full Text] [Related]
35. HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients.
Estrella M; Fine DM; Gallant JE; Rahman MH; Nagajothi N; Racusen LC; Scheel PJ; Atta MG
Clin Infect Dis; 2006 Aug; 43(3):377-80. PubMed ID: 16804855
[TBL] [Abstract][Full Text] [Related]
36. Complications of HIV infection: a systems-based approach.
Chu C; Selwyn PA
Am Fam Physician; 2011 Feb; 83(4):395-406. PubMed ID: 21322514
[TBL] [Abstract][Full Text] [Related]
37. Solid organ transplantation in HIV-infected individuals: an update.
Huprikar S
Rev Med Virol; 2009 Nov; 19(6):317-23. PubMed ID: 19554551
[TBL] [Abstract][Full Text] [Related]
38. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
[TBL] [Abstract][Full Text] [Related]
39. Improvements in antiretroviral therapy outcomes over calendar time.
Boyd MA
Curr Opin HIV AIDS; 2009 May; 4(3):194-9. PubMed ID: 19532050
[TBL] [Abstract][Full Text] [Related]
40. [HIV nephropathy and other kidney diseases in patients with human immunodeficiency virus infections].
Brzósko S; Myśliwiec M
Przegl Lek; 2000; 57(3):160-4. PubMed ID: 10909287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
